Published in Medical Letter on the CDC and FDA, January 29th, 2006
Among new claims added to the package insert is 94% sensitivity for detecting influenza A when using nasal swab specimens. The package insert for the test is being updated to include clinical study results for nasal swab, nasopharyngeal swab and nasal wash in addition to analytical study results for the detection of cultured avian influenza viruses.
The QuickVue Influenza A+B test has been shown to detect cultured avian influenza viruses,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.